Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01772550 · ClinicalTrials.gov registry record · NA
Study of Effectiveness of Smaller Gauge Fenestrated Catheters for Use in IV Contrast Enhanced CT Scans
A NA study of Contrast Enhanced Computed Tomography, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- NA
- Development phase
- 238
- Enrollment target
- 1
- Study location
NCT01772550: Completed NA study of Contrast Enhanced Computed Tomography, sponsored by Becton, Dickinson and Company.
NCT01772550 is a NA study of Contrast Enhanced Computed Tomography that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 238 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01772550, a NA study of Contrast Enhanced Computed Tomography, has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 238 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare multidetector computed tomography (CT) image quality following peripheral venous high pressure injection of iodinated intravenous contrast media between a 20 gauge (GA) fenestrated, intravenous catheter (BD Nexiva™ Diffusics™) and an 18 GA non-fenestrated, intravenous catheter. In the contrast enhanced CT procedure (CECT), a machine (power injector) is used to rapidly deliver contrast agent to an individual's circulatory system. The contrast allows for greater differentiation of tissues in images of the area of interest, affording a better opportunity to visually assess the area and hence make a more accurate diagnosis. CECT often requires a high rate of contrast flow (≥ 5 mL/sec) through the IV catheter to provide sufficient contrast for an acceptable image. Typically an 18 GA IV catheter is required to achieve these high flow rates; however, often the patient does not have a vein that will accommodate this large size catheter. The BD Nexiva™ Diffusics™ IV catheter is designed to deliver a higher flow rate than a conventional catheter of the same gauge by incorporating fenestrations (small openings) near the tip of the catheter that allow fluid to exit the catheter in addition to that which normally exits through the main opening at the tip of the catheter.
Primary Outcome
Study images were assessed by a US board-certified radiologist to determine whether the image is of acceptable quality. The radiologist was not informed of the study device used for the injection that produced the image under evaluation. Subjective image quality assessment for acceptability was determined by: * The report of the reading radiologist in the section of the report where the radiologist indicates if the image is acceptable or not. The absence of a comment in this section will be int
Conditions Studied
Interventions
- DEVICE 20GA BD Nexiva Diffusics
- DEVICE 18GA Conventional Catheter
Study Locations (1)
Maryland
- Johns Hopkins Outpatient Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-02 |
| Phase | NA |
What the finished NCT01772550 record still lists
NCT01772550 is an interventional study that assigns participants to a tested intervention. The registered 238 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Contrast Enhanced Computed Tomography appearing as the primary indexed condition, and to 2 interventions - of which 20GA BD Nexiva Diffusics is the first listed.
NCT01772550 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01772550 about?
NCT01772550 is a clinical study titled "Study of Effectiveness of Smaller Gauge Fenestrated Catheters for Use in IV Contrast Enhanced CT Scans". The purpose of this study is to compare multidetector computed tomography (CT) image quality following peripheral venous high pressure injection of iodinated intravenous contrast media between a 20 gauge (GA) fenestrated, intravenous catheter (BD Nexiva™ Diffusics™) and an 18 GA non-fenestrated, int...
What is the current status of trial NCT01772550?
This trial is currently completed. It is a NA study. The enrollment target is 238 participants. The study started on 2013-01. Estimated completion is 2013-02.
What conditions does trial NCT01772550 study?
This clinical trial studies the following conditions: Contrast Enhanced Computed Tomography.
What interventions are being tested in trial NCT01772550?
The interventions under investigation include: 20GA BD Nexiva Diffusics (DEVICE), 18GA Conventional Catheter (DEVICE).
Who is sponsoring clinical trial NCT01772550?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01772550 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01772550's enrollment target sits among peer trials
238 459th of 2000 higher than 1,540 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05012072 · 238 participants · NA
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
- NCT05400252 · 238 participants · NA
Whole Health in VA Mental Health: Omnis Salutis
- NCT06380517 · 238 participants · Phase 3
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
- NCT06452797 · 238 participants · NA
Prognostic Estimates Among ICU Clinicians
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia